The human cathelicidin LL-37 has antiviral activity against respiratory syncytial virus.
Respiratory syncytial virus is a leading cause of lower respiratory tract illness among infants, the elderly and immunocompromised individuals. Currently, there is no effective vaccine or disease modifying treatment available and novel interventions are urgently required. Cathelicidins are cationic...
Saved in:
| Main Authors: | Silke M Currie, Emily Gwyer Findlay, Brian J McHugh, Annie Mackellar, Tian Man, Derek Macmillan, Hongwei Wang, Paul M Fitch, Jürgen Schwarze, Donald J Davidson |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0073659 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37.
by: Peter G Barlow, et al.
Published: (2011-01-01) -
Cathelicidin peptide LL-37: A multifunctional peptide involved in heart disease
by: Shuo Miao, et al.
Published: (2024-12-01) -
Serum concentrations of antimicrobial peptide cathelicidin LL-37 in patients with bacterial lung infections
by: Karol Majewski, et al.
Published: (2018-12-01) -
Cathelicidin host defence peptide augments clearance of pulmonary Pseudomonas aeruginosa infection by its influence on neutrophil function in vivo.
by: Paula E Beaumont, et al.
Published: (2014-01-01) -
Cathelicidin LL-37 Affects Surface and Intracellular Toll-Like Receptor Expression in Tissue Mast Cells
by: Justyna Agier, et al.
Published: (2018-01-01)